NEU neuren pharmaceuticals limited

UBS is an interesting case study KJK; if they truly are the...

  1. 2,109 Posts.
    lightbulb Created with Sketch. 551
    UBS is an interesting case study KJK; if they truly are the culprit in the denigration of our SP and NEU has bought up their cheap stock relieving the opportunity of that stock to double or more then UBS may now decide to support the SP by buying in and therefore assisting in NEU’s plight, reverse psychology if you think of it, who knows.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.